Filing Details

Accession Number:
0001209191-15-005233
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-20 17:28:03
Reporting Period:
2015-01-20
Filing Date:
2015-01-20
Accepted Time:
2015-01-20 17:28:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236934 J Paula Swain 1801 Augustine Cut-Off
Wilmington DE 19803
Evp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-20 17,500 $3.11 38,583 No 4 M Direct
Common Stock Disposition 2015-01-20 17,500 $74.17 21,083 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-01-20 17,500 $0.00 17,500 $3.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
51,469 2016-01-26 No 4 M Direct
Footnotes
  1. Represents weighted average sale price. Actual sale prices ranged from $73.19 - $74.81.
  2. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
  3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  4. Beginning January 27, 2009, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.